Risk Factors for Cardiovascular Disease in Children Infected with Human Immunodeficiency Virus-1

Tracie L. Miller, E. John Orav, Steven E. Lipshultz, Kristopher L. Arheart, Christopher Duggan, Geoffrey A. Weinberg, Lori Bechard, Lauren Furuta, Jeanne Nicchitta, Sherwood L. Gorbach, Abby Shevitz

Research output: Contribution to journalArticle

45 Scopus citations

Abstract

Objective: To determine risk factors for cardiovascular disease (CVD) in children infected with human immunodeficiency virus (HIV) compared with nationally representative controls from 2003-2004 National Health and Nutrition Examination Survey (NHANES) data. Study design: A prospective, longitudinal analysis of CVD risk factors in 42 HIV-infected children compared with NHANES controls, with multivariable modeling of demographic, disease-specific, and treatment-related factors contributing to cardiac risk in the HIV cohort. Results: The 42 children infected with HIV were initially an average of 10.1 years old; 68% were Centers for Disease Control and Prevention pediatric HIV disease stage B or C, and 76% were receiving highly active antiretroviral therapy (HAART). Compared with age- and sex-adjusted NHANES controls, the children infected with HIV had lower weight (-0.46 standard deviation [SD] vs +0.54 SD; P < .001), height (-0.62 SD vs +0.26 SD; P < .001), and body mass index (-0.09 SD vs +0.51 SD; P < .001), a higher level of triglycerides (136 mg/dL vs 90 mg/dL; P < .001), and a lower level of high-density lipoprotein (HDL) cholesterol (47 mg/dL vs 54 mg/dL; P < .001). Protease inhibitor therapy was independently associated with higher triglyceride (P = .02) and low-density lipoprotein cholesterol levels (P = .04) and lower HDL cholesterol level (P = .02); nonnucleoside reverse-transcriptase inhibitor therapy was associated with lower visceral fat (P = .01) and higher HDL cholesterol level (P = .005). Conclusions: Children infected with HIV have adverse cardiac risk profiles compared with NHANES controls. Antiretroviral therapy has a significant influence on these factors.

Original languageEnglish (US)
Pages (from-to)491-497
Number of pages7
JournalJournal of Pediatrics
Volume153
Issue number4
DOIs
StatePublished - Oct 2008

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Fingerprint Dive into the research topics of 'Risk Factors for Cardiovascular Disease in Children Infected with Human Immunodeficiency Virus-1'. Together they form a unique fingerprint.

  • Cite this

    Miller, T. L., Orav, E. J., Lipshultz, S. E., Arheart, K. L., Duggan, C., Weinberg, G. A., Bechard, L., Furuta, L., Nicchitta, J., Gorbach, S. L., & Shevitz, A. (2008). Risk Factors for Cardiovascular Disease in Children Infected with Human Immunodeficiency Virus-1. Journal of Pediatrics, 153(4), 491-497. https://doi.org/10.1016/j.jpeds.2008.04.016